EARLY SWITCH THERAPY APPROACH FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

被引：0
|
作者：
Shukhov, O. [1 ]
Chelysheva, E. [1 ]
Gusarova, G. [1 ]
Abdullaev, A. [2 ]
Sudarikov, A. [2 ]
Obukhova, T. [2 ]
Turkina, A. [1 ]
机构：
[1] Sci & Advisory Dept Chemotherapy Myeloproliferat, Moscow, Russia
[2] Hlth Minist Russian Federat, Fed State Budgetary Inst Hematol Res Ctr, Moscow, Russia
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1559
引用
收藏
页码：604 / 604
页数：1
相关论文
共 50 条
  • [21] Comparative proteomic analysis of chronic myeloid leukemia patients in chronic phase
    Pizzatti, L.
    Sa, L.
    Souza, J.
    Bisch, P.
    Abdelhay, E.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S126 - S126
  • [22] Effects of Ramadan Fasting in Patients with Chronic Myeloid Leukemia in Chronic Phase
    Yassin, Mohamed A.
    Ghasoub, Rola S.
    Aldapt, Mahmood B.
    Abdulla, Mohammad Abdul-Jaber
    Chandra, Prem
    Shwaylia, Hawraa M.
    Nashwan, Abdulqadir Jeprel
    Kassem, Nancy
    Akiki, Susanna Jane
    BLOOD, 2019, 134
  • [23] Chronic Myeloid Leukemia: Reversing the Chronic Phase
    Goldman, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 363 - 365
  • [24] Gleevek therapy resistance in patients with chronic myeloid leukemia in the acceleration phase.
    Kruglov, S. S.
    Turkina, A. G.
    Khoroshko, N. D.
    Abakumov, E. M.
    Druzhkova, G. A.
    Zakharova, A. V.
    Domracheva, E. V.
    Kolosheinova, T. I.
    Kolosova, L. Yu.
    Kovalyova, L. G.
    Dyachenko, L. V.
    Chelysheva, E. Yu.
    Chernova, L. A.
    Loriya, S. S.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (02): : 17 - 24
  • [25] The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
    Wolfe, Heather R.
    Rein, Lindsay A. M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 448 - 454
  • [26] Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase
    Popovici, Despina Calamar
    Ionita, Ioana
    Nedelcu, Mirela
    Ionita, Claudiu
    Ionita, Hortensia
    Moleriu, Radu Dumitru
    Ilie, Calin Ovidiu
    Iacob, Daniela
    Constantin, Luca Tudor
    Cheveresan, Adelina
    Vaduva, Delia Berceanu
    Radu, Daniela
    REVISTA DE CHIMIE, 2019, 70 (08): : 3017 - 3020
  • [27] The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)
    Heather R. Wolfe
    Lindsay A. M. Rein
    Current Hematologic Malignancy Reports, 2021, 16 : 448 - 454
  • [28] An evaluation of ponatinib as a therapy in adult patients with resistant/intolerant chronic-phase chronic myeloid leukemia
    Yang, Jay
    Surapaneni, Malini
    Schiffer, Charles A.
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (05) : 393 - 402
  • [29] Nilotinib As Second-Line Therapy in Patients with Chronic Myeloid Leukemia in Chronic Phase: Thailand Experience
    Chansung, Kanchana
    Sirijerachai, Chittima
    Lekhakula, Arnuparp
    Viboonjuntra, Pongtep
    Niparuck, Pimjai
    Pauvilai, Teeraya
    Numbenjapon, Tontanai
    Bunworasate, Udomsak
    Nawarawong, Weerasak
    Tantiworawit, Adisak
    Suwanban, Tawatchai
    Jootar, Saengsuree
    BLOOD, 2016, 128 (22)
  • [30] Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease
    Smith, Catherine C.
    Shah, Neil P.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 121 - 127
12345